IL124522A0 - Quinoline derivatives - Google Patents
Quinoline derivativesInfo
- Publication number
- IL124522A0 IL124522A0 IL12452296A IL12452296A IL124522A0 IL 124522 A0 IL124522 A0 IL 124522A0 IL 12452296 A IL12452296 A IL 12452296A IL 12452296 A IL12452296 A IL 12452296A IL 124522 A0 IL124522 A0 IL 124522A0
- Authority
- IL
- Israel
- Prior art keywords
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI002461 IT1276170B1 (it) | 1995-11-24 | 1995-11-24 | Derivati chinolinici |
| ITMI961689 IT1307331B1 (it) | 1996-08-02 | 1996-08-02 | Derivati chinolinici |
| PCT/EP1996/005203 WO1997021680A1 (en) | 1995-11-24 | 1996-11-22 | Quinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL124522A0 true IL124522A0 (en) | 1998-12-06 |
Family
ID=26331326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12452296A IL124522A0 (en) | 1995-11-24 | 1996-11-22 | Quinoline derivatives |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6277862B1 (OSRAM) |
| EP (1) | EP0876347B1 (OSRAM) |
| JP (1) | JP2000501104A (OSRAM) |
| KR (1) | KR19990071597A (OSRAM) |
| CN (1) | CN1207730A (OSRAM) |
| AP (1) | AP9801237A0 (OSRAM) |
| AR (1) | AR004972A1 (OSRAM) |
| AT (1) | ATE289994T1 (OSRAM) |
| BG (1) | BG102558A (OSRAM) |
| BR (1) | BR9611820A (OSRAM) |
| CA (1) | CA2238298A1 (OSRAM) |
| CZ (1) | CZ157998A3 (OSRAM) |
| DE (1) | DE69634416T2 (OSRAM) |
| EA (1) | EA002124B1 (OSRAM) |
| ES (1) | ES2236757T3 (OSRAM) |
| IL (1) | IL124522A0 (OSRAM) |
| MX (1) | MX9804107A (OSRAM) |
| NO (1) | NO311212B1 (OSRAM) |
| NZ (1) | NZ323387A (OSRAM) |
| OA (1) | OA11010A (OSRAM) |
| PL (1) | PL326967A1 (OSRAM) |
| SK (1) | SK66798A3 (OSRAM) |
| TR (1) | TR199800924T2 (OSRAM) |
| TW (1) | TW353066B (OSRAM) |
| UY (1) | UY24733A1 (OSRAM) |
| WO (1) | WO1997021680A1 (OSRAM) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU664392B2 (en) * | 1991-10-18 | 1995-11-16 | Monsanto Technology Llc | Fungicides for the control of take-all disease of plants |
| SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
| SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| GB9825554D0 (en) * | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
| US7037922B1 (en) * | 2000-03-10 | 2006-05-02 | Neurogen Corporation | Aryl fused 2,4-disubstituted pyridines: NK3 receptor ligands |
| EP1165542B1 (en) | 1999-03-29 | 2003-08-20 | Neurogen Corporation | 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands |
| WO2000064877A1 (en) * | 1999-04-26 | 2000-11-02 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
| JP2004525184A (ja) * | 2001-04-11 | 2004-08-19 | グラクソスミスクライン・ソシエタ・ペル・アチオニ | Ｎｋ−３およびｎｋ−２受容体アンタゴニストとしての３−置換キノリン−４−カルボキサミド誘導体 |
| WO2002089802A2 (en) * | 2001-05-08 | 2002-11-14 | Schering Corporation | Use of neurokinin receptor antagonists to treat androgen-dependent diseases |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| ATE477268T1 (de) | 2003-01-28 | 2010-08-15 | Ironwood Pharmaceuticals Inc | Zusammensetzungen zur behandlung von magen-darm- störungen |
| GB0303086D0 (en) | 2003-02-11 | 2003-03-19 | Merck Sharp & Dohme | New compounds |
| GB0419192D0 (en) | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
| WO2006052722A1 (en) * | 2004-11-09 | 2006-05-18 | Smithkline Beecham Corporation | Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| GB0425077D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
| EP1915361A1 (en) * | 2005-08-11 | 2008-04-30 | AstraZeneca AB | Alkylpyridyl quinolines as nk3 receptor modulators |
| AR057130A1 (es) | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
| TW201018662A (en) * | 2005-12-12 | 2010-05-16 | Astrazeneca Ab | Alkylsulphonamide quinolines |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| MX2010003440A (es) * | 2007-09-28 | 2010-04-21 | Glaxosmithkline Llc | Compuesto inhibidor de glicogeno fosforilasa y composicion farmaceutica del mismo. |
| JP2010540553A (ja) * | 2007-09-28 | 2010-12-24 | グラクソスミスクライン エルエルシー | グリコーゲンホスホリラーゼ阻害剤化合物及びその医薬組成物 |
| EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| JP5502106B2 (ja) | 2008-12-31 | 2014-05-28 | アーデリクス，インコーポレーテッド | 体液貯留または塩分過負荷と関連する障害および消化管障害の治療におけるｎｈｅ媒介性アンチポートを阻害するための組成物および方法 |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| KR102138390B1 (ko) | 2012-08-21 | 2020-07-27 | 알데릭스, 인코포레이티드 | 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료에서 ｎｈｅ-매개된 역수송 저해를 위한 화합물 및 방법 |
| HK1220696A1 (zh) | 2013-03-15 | 2017-05-12 | Bausch Health Ireland Limited | 鸟苷酸环化酶激动剂及其用途 |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| KR102287207B1 (ko) | 2013-04-12 | 2021-08-09 | 알데릭스, 인코포레이티드 | Nhe3-결합 화합물 및 포스페이트 수송을 저해하는 방법 |
| AU2014255512A1 (en) | 2013-04-19 | 2015-11-12 | Astrazeneca Ab | A NK3 receptor antagonist compound (NK3RA) for use in a method for the treatment of polycystic ovary syndrome (PCOS) |
| EP4424697A3 (en) | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| WO2017072629A1 (en) | 2015-10-29 | 2017-05-04 | Cadila Healthcare Limited | Pharmaceutical combination of nk3 receptor antagonist and biguanides |
| CA3049679A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Inhibitors of nhe-mediated antiport |
| UA126283C2 (uk) | 2017-01-09 | 2022-09-14 | Арделікс, Інк. | Сполуки, придатні для лікування розладів шлунково-кишкового тракту |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2538388B1 (fr) * | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| JPS63119455A (ja) * | 1986-06-27 | 1988-05-24 | Nippon Shinyaku Co Ltd | グリシン誘導体 |
| CA2191352C (en) * | 1994-05-27 | 2001-01-30 | Carlo Farina | Quinoline derivatives as tachykinin nk3 receptor antagonists |
| IT1270615B (it) * | 1994-07-14 | 1997-05-07 | Smithkline Beecham Farma | Uso di derivati di chinolina |
-
1996
- 1996-11-22 EA EA199800477A patent/EA002124B1/ru not_active IP Right Cessation
- 1996-11-22 CZ CZ981579A patent/CZ157998A3/cs unknown
- 1996-11-22 SK SK667-98A patent/SK66798A3/sk unknown
- 1996-11-22 WO PCT/EP1996/005203 patent/WO1997021680A1/en not_active Ceased
- 1996-11-22 ES ES96941023T patent/ES2236757T3/es not_active Expired - Lifetime
- 1996-11-22 BR BR9611820A patent/BR9611820A/pt not_active Application Discontinuation
- 1996-11-22 AP APAP/P/1998/001237A patent/AP9801237A0/en unknown
- 1996-11-22 IL IL12452296A patent/IL124522A0/xx unknown
- 1996-11-22 TR TR1998/00924T patent/TR199800924T2/xx unknown
- 1996-11-22 DE DE69634416T patent/DE69634416T2/de not_active Expired - Fee Related
- 1996-11-22 PL PL96326967A patent/PL326967A1/xx unknown
- 1996-11-22 JP JP9521658A patent/JP2000501104A/ja active Pending
- 1996-11-22 CN CN96199753A patent/CN1207730A/zh active Pending
- 1996-11-22 CA CA002238298A patent/CA2238298A1/en not_active Abandoned
- 1996-11-22 EP EP96941023A patent/EP0876347B1/en not_active Expired - Lifetime
- 1996-11-22 KR KR1019980703873A patent/KR19990071597A/ko not_active Withdrawn
- 1996-11-22 NZ NZ323387A patent/NZ323387A/en unknown
- 1996-11-22 AT AT96941023T patent/ATE289994T1/de not_active IP Right Cessation
- 1996-11-22 US US09/077,151 patent/US6277862B1/en not_active Expired - Fee Related
- 1996-11-23 TW TW085114500A patent/TW353066B/zh active
- 1996-11-25 AR ARP960105317A patent/AR004972A1/es not_active Application Discontinuation
-
1997
- 1997-09-30 UY UY24733A patent/UY24733A1/es not_active Application Discontinuation
-
1998
- 1998-05-22 MX MX9804107A patent/MX9804107A/es unknown
- 1998-05-22 NO NO19982331A patent/NO311212B1/no unknown
- 1998-05-22 OA OA9800061A patent/OA11010A/en unknown
- 1998-06-18 BG BG102558A patent/BG102558A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO311212B1 (no) | 2001-10-29 |
| CZ157998A3 (cs) | 1998-12-16 |
| SK66798A3 (en) | 1999-01-11 |
| EP0876347A1 (en) | 1998-11-11 |
| NZ323387A (en) | 2000-02-28 |
| BG102558A (bg) | 1999-03-31 |
| DE69634416D1 (de) | 2005-04-07 |
| WO1997021680A1 (en) | 1997-06-19 |
| NO982331L (no) | 1998-07-22 |
| TW353066B (en) | 1999-02-21 |
| JP2000501104A (ja) | 2000-02-02 |
| ES2236757T3 (es) | 2005-07-16 |
| BR9611820A (pt) | 1999-07-13 |
| TR199800924T2 (xx) | 1998-08-21 |
| AR004972A1 (es) | 1999-04-07 |
| KR19990071597A (ko) | 1999-09-27 |
| PL326967A1 (en) | 1998-11-09 |
| UY24733A1 (es) | 2001-08-27 |
| NO982331D0 (no) | 1998-05-22 |
| AP9801237A0 (en) | 1998-06-30 |
| EP0876347B1 (en) | 2005-03-02 |
| DE69634416T2 (de) | 2005-12-29 |
| OA11010A (en) | 2003-03-06 |
| ATE289994T1 (de) | 2005-03-15 |
| US6277862B1 (en) | 2001-08-21 |
| EA199800477A1 (ru) | 1998-12-24 |
| CA2238298A1 (en) | 1997-06-19 |
| EA002124B1 (ru) | 2001-12-24 |
| MX9804107A (es) | 1998-09-30 |
| CN1207730A (zh) | 1999-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL124522A0 (en) | Quinoline derivatives | |
| AP9500745A0 (en) | Quinoline derivatives | |
| NZ305444A (en) | 4-anilino-7-alkoxy-quinazoline derivatives | |
| IL152383A0 (en) | 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives | |
| IL135376A0 (en) | Hydroxyalkyl-phenyl derivatives | |
| GB2306473A8 (en) | Glucoxide derivatives | |
| HU9603071D0 (en) | Purin-6-one derivatives | |
| HU9600876D0 (en) | Benzonitril- and -fluoride derivatives | |
| ZA977326B (en) | Tetrahydroquinoline derivatives | |
| ZA969812B (en) | Novel quinoline derivatives. | |
| NZ332395A (en) | Benzonthiazole derivatives | |
| HU9600107D0 (en) | 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives | |
| SI0758644T1 (en) | Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives | |
| SG60005A1 (en) | 1-Fluorocyclohexene-difluorophenyl derivatives | |
| HUP9900672A3 (en) | Pyrroloazepine derivatives | |
| IL123621A0 (en) | Diarylalkenylamine derivatives | |
| GB9404378D0 (en) | Quinoline derivatives | |
| GR3035577T3 (en) | Benzisothiazolyl-substituted aminomethylchroman derivatives | |
| IL117858A0 (en) | 4-Indolypiperazinyl derivatives | |
| ZA954269B (en) | Quinoline derivatives | |
| GR3036572T3 (en) | 4-amino-benzoylguanidine derivatives | |
| GB9413150D0 (en) | Quinoline derivatives | |
| GB9402275D0 (en) | Quinoline derivatives | |
| HU9602324D0 (en) | Piperidinyl-methyl-oxazolidinon derivatives | |
| EP0754668A3 (de) | Fluorbenzylether-Derivate |